Hostname: page-component-7c8c6479df-995ml Total loading time: 0 Render date: 2024-03-19T06:50:15.141Z Has data issue: false hasContentIssue false

Sites of Colonization with Extended-Spectrum β-Lactamases (ESBL)-Producing Enterobacteriaceae: The Rationale for Screening

Published online by Cambridge University Press:  02 January 2015

Sarah Tschudin-Sutter
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
Reno Frei
Affiliation:
Division of Clinical Microbiology, University Hospital Basel, Basel, Switzerland
Marc Dangel
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
Anne Stranden
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
Andreas Franz Widmer*
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
*
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland (widmera@uhbs.ch)

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Briefs
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Peleg, AY, Hooper, DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010;362(19):18041813.CrossRefGoogle ScholarPubMed
2.Pitout, JDD, Laupland, KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8(3):159166.Google Scholar
3.Lautenbach, E, Patel, JB, Bilker, WB, Edelstein, PH, Fishman, NO. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32(8):11621171.Google Scholar
4.Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L; and the Healthcare Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. http://www.cdc.gov/hicpac/pdf/isolation/isolation2007.pdf.Google Scholar
5.Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement. Wayne, PA: CLSI, 2008. CLSI document M100-S18.Google Scholar
6.Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48(1):114.Google Scholar
7.Xu, L, Ensor, V, Gossain, S, Nye, K, Hawkey, P. Rapid and simple detection of bla CTX-M genes by multiplex PCR assay. J Med Microbiol 2005;54(12):11831187.Google Scholar
8.Christiaens, G, Ciccarella, Y, Damas, P, et al.Prospective survey of digestive tract colonization with Enterobacteriaceae that produce extended-spectrum β-lactamases in intensive care units. J Hosp Infect 2006;62(3):386388.Google Scholar
9.Reddy, P, Malczynski, M, Obias, A, et al.Screening for extended-spectrum β-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 2007;45(7):846852.Google Scholar
10.Pitout, JDD, Nordmann, P, Laupland, KB, Poirel, L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56(1):5259.Google Scholar